Logos Capital (investor - Private Equity)
See something wrong or missing? Let us know
Offices:New York
Average round investment:272.5M USD
Average number per year:2.0
Distribution:
2024 (2)
Portfolio companies:
Verdiva Bio
Adcendo


Mostly invests in:
United Kingdom (1)
Biotech (2)

2 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.